Investigación / Grupos de investigación

Grupo  1

Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Publicaciones (897)

  • Vieta, E; Ahmed, N; Arango, C; Cleare, AJ; Demyttenaere, K; Dold, M; Ito, T; Kambarov, Y; Krüger, S; Llorca, PM; Mcintyre, RS; Sani, G; von Holt, C; Rive, B.

    Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study

    EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 93: 29-39 Nº de citas: 6 [doi:10.1016/j.euroneuro.2024.12.013]

  • Ballem R; Andrés-Camazón P; Jensen KM; Bajracharya P; Díaz-Caneja CM; Bustillo JR; Turner JA; Fu Z; Chen J; Calhoun VD; Iraji A.

    Mapping the Psychosis Spectrum - Imaging Neurosubtypes from Multi-Scale Functional Network Connectivity.

    Biorxiv : The Preprint Server For Biology. 2025; : [doi:10.1101/2025.02.11.637551]

  • Dominguez-Alonso, S; Tubio-Fungueiriño, M; Gonzalez-Peñas, J; Fernandez-Prieto, M; Parellada, M; Arango, C; Carracedo, A; Rodriguez-Fontenla, C.

    Alternative splicing analysis in a Spanish ASD (Autism Spectrum Disorders) cohort: in silico prediction and characterization

    Scientific Reports. 2025; 15(1): Nº de citas: 1 [doi:10.1038/s41598-025-95456-2]

  • Allott, K; Yassin, W; Alameda, L; Billah, T; Borders, O; Buccilli, K; Carrión, RE; Castillo-Passi, RI; Cho, KIK; Chin, K; Coleman, MJ; Colton, BL; Corral, S; Dwyer, D; Gundersen, KB; Gur, RC; Hoftman, GD; Jacobs, GR; Kelly, S; Lewandowski, KE; Marcy, PJ; Matneja, P; Mclaughlin, D; Nunez, AR; Parsa, S; Penzel, N; Ray, S; Reinen, JM; Ruparel, K; Sand, MS; Santorelli, G; Seitz-Holland, J; Spark, J; Tamayo, Z; Thompson, A; Tod, S; Wannan, CMJ; Wickham, A; Wood, SJ; Zoupou, E; Addington, J; Anticevic, A; Arango, C; Breitborde, NJK; Broome, MR; Cadenhead, KS; Calkins, ME; Chen, EYH; Choi, J; Conus, P; Corcoran, CM; Cornblatt, BA; Ellman, LM; Fusar-Poli, P; Gaspar, PA; Gerber, C; Glenthoj, LB; Horton, LE; Hui, CLM; Kambeitz, J; Kambeitz-Ilankovic, L; Keshavan, M; Kim, SW; Koutsouleris, N; Kwon, JS; Langbein, K; Mamah, D; Diaz-Caneja, CM; Mathalon, DH; Mittal, VA; Nordentoft, M; Pearlson, GD; Perkins, DO; Perez, J; Powers, AR III; Rogers, J; Sabb, FW; Schiffman, J; Shah, JL; Silverstein, SM; Smesny, S; Strauss, GP; Thompson, JL; Upthegrove, R; Verma, SK; Wang, JJ; Wolf, DH; Pasternak, O; Bouix, S; Mcgorry, PD; Kane, JM; Kahn, RS; Bearden, CE; Shenton, ME; Woods, SW; Nelson, B; Accelerating Med Partnership; Stone, WS.

    Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample

    Schizophrenia. 2025; 11(1): Nº de citas: 6 [doi:10.1038/s41537-025-00578-1]

  • Andrés-Camazón, P; Diaz-Caneja, CM; Ballem, R; Chen, JY; Calhoun, VD; Iraji, A.

    Neurobiology-based cognitive biotypes using multi-scale intrinsic connectivity networks in psychotic disorders

    Schizophrenia. 2025; 11(1): Nº de citas: 2 [doi:10.1038/s41537-025-00593-2]

  • Díaz-Ruíz, R; Poca, M; Román, E; Cuyàs, B; Bañares, I; Morales, A; Martínez-Esparza, EH; Panadero, R; Velasco, C; Rapado-Castro, M; Bretón, I; Banares, R; Soriano, G; García-Martínez, R.

    Treatment of Vitamin D Deficiency in Decompensated Patients with Cirrhosis Is Associated with Improvement in Frailty

    Medical Sciences. 2025; 13(1): Nº de citas: 2 [doi:10.3390/medsci13010030]

  • Chart-Pascual, JP; Goena, J; Lara, F; Torres, MM; Napal, JM; Muñoz, R; Montero, CG; Martínez, OF; Ortega, MA; de Pablo, GS; Pinto, AG; Quintero, J; Alvarez-Mon, M; Alvarez-Mon, MA.

    Understanding social media discourse on antidepressants: unsupervised and sentiment analysis using X

    EUROPEAN PSYCHIATRY. 2025; 68(1): Nº de citas: 4 [doi:10.1192/j.eurpsy.2025.10]

  • Fernández, AG; Brenlla, E; Caro-Cañizares, I; Esteban, AC; Carballo, JJ.

    Adolescent Females as a Group Particularly Vulnerable to Suicide Risk and Traumatic Stressful Life Events

    Early Intervention in Psychiatry. 2025; 19(3): [doi:10.1111/eip.70022]

  • Aymerich C; Bullock E; Rowe SMB; Catalan A; Salazar de Pablo G.

    Aggressive Behavior in Children and Adolescents With Bipolar Spectrum Disorder: A Systematic Review of the Prevalence, Associated Factors, and Treatment.

    Jaacap Open. 2025; 3(1): 42-55 [doi:10.1016/j.jaacop.2024.02.009]

  • Gil-Berrozpe, GJ; Segura, AG; Sánchez-Torres, AM; Amoretti, S; Giné-Servén, E; Vieta, E; Mezquida, G; Lobo, A; Gonzalez-Pinto, A; Andreu-Bernabeu, A; Roldán, A; Forte, MF; Castro, J; Bergé, D; Rodríguez, N; Ballesteros, A; Mas, S; Cuesta, MJ; Bernardo, M; PEPs Grp.

    Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach

    EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 92: 52-61 Nº de citas: 6 [doi:10.1016/j.euroneuro.2024.12.002]

  • Bioque, M; Llorca-Bofi, V; MacDowell, KS; Amoretti, S; Mezquida, G; Cuesta, MJ; Diaz-Caneja, CM; Ibáñez, A; Segarra, R; González-Pinto, A; Roldán, A; Sáiz, PA; Mané, A; Lobo, A; Martínez-Pinteño, A; Cano-Escalera, G; Berrocoso, E; Bernardo, M.

    Impact of Relapse in BDNF Receptors Expression in Patients With a First Episode of Schizophrenia

    SCHIZOPHRENIA BULLETIN. 2025; : [doi:10.1093/schbul/sbaf012]

  • Ferraro, L; Di Forti, M; La Barbera, D; La Cascia, C; Morgan, C; Tripoli, G; Jongsma, H; Seminerio, F; Sartorio, C; Sideli, L; Tarricone, I; Carloni, AL; Szoke, A; Pignon, B; Bernardo, M; de Haan, L; Arango, C; Velthorst, E; Gayer-Anderson, C; Kirkbride, J; Rutten, BPF; Lasalvia, A; Tosato, S; Del Ben, CM; Menezes, PR; Bobes, J; Arrojo, M; Tortelli, A; Jones, P; Selten, JP; van Os, J; Murray, R; Quattrone, D; Vassos, E.

    Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors

    PSYCHOLOGICAL MEDICINE. 2025; 55: Nº de citas: 2 [doi:10.1017/S0033291724003507]

  • de-la-Higuera-Gonzalez, P; Rodriguez-Toscano, E; Diaz-Carracedo, P; Gonzalez-Urrea, MJ; Padilla-Quiles, G; Diaz-Marsa, M; de la Torre-luque, A.

    Memory deficits in children and adolescents with a psychotic disorder: a systematic review and meta-analysis

    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2025; 275(3): 715-732 Nº de citas: 1 [doi:10.1007/s00406-025-01961-w]

  • Ortiz, M; Pueyo, A; Dongil, FJ; Boquete, L; Sánchez-Morla, EM; Barea, R; Miguel-Jimenez, JM; López-Dorado, A; Vilades, E; Rodrigo, MJ; Cordon, B; Garcia-Martin, E.

    New Method of Early RRMS Diagnosis Using OCT-Assessed Structural Retinal Data and Explainable Artificial Intelligence

    Translational Vision Science & Technology. 2025; 14(2): Nº de citas: 1 [doi:10.1167/tvst.14.2.14]

  • Saracaydin, G; van Rooij, D; Kleine-Deters, R; Messchendorp, M; Naaijen, J; Penzol, MJ; Rosa, M; Aggensteiner, PM; Baumeister, S; Holz, N; Banaschewski, T; Saam, M; Schulze, UME; Sethi, A; Craig, M; Castro-Fornieles, J; Arango, C; Walitza, S; Werhahn, J; Brandeis, D; Franke, B; Ruisch, IH; Buitelaar, JK; Dietrich, A; Hoekstra, PJ.

    Disentangling the neural underpinnings of response inhibition in disruptive behavior and co-occurring ADHD

    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2025; : [doi:10.1007/s00787-025-02638-4]

  • Stringaris, A; Burman, C; Delpech, R; Uher, R; Bhudia, D; Miliou, D; Rokas, IM; Kyriakopoulos, M; Foulkes, L; Moreno, C; Cortese, S; Lewis, G; Krebs, G.

    Comparing apples and oranges in youth depression treatments? A quantitative critique of the evidence base and guidelines

    BMJ Mental Health. 2025; 28(1): Nº de citas: 5 [doi:10.1136/bmjment-2024-301162]

  • Bond, BW; Duric, B; Spinazzola, E; Trotta, G; Chesney, E; Li, ZK; Quattrone, D; Tripoli, G; Gayer-Anderson, C; Rodriguez, V; Ferraro, L; La Cascia, C; Tarricone, I; Szöke, A; Arango, C; Bobes, J; Bernardo, M; Del-Ben, CM; Menezes, PR; Selten, JP; Rutten, BPF; de Haan, L; Stilo, S; Schürhoff, F; Pignon, B; Freeman, TP; Vassos, E; Murray, RM; Austin-Zimmerman, I; Di Forti, M.

    Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques

    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE. 2025; 70(3): 182-193 [doi:10.1177/07067437241290187]

  • Persico, AM; Asta, L; Chehbani, F; Mirabelli, S; Parlatini, V; Cortese, S; Arango, C; Vitiello, B.

    The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part II: The future

    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2025; 136: Nº de citas: 8 [doi:10.1016/j.pnpbp.2024.111176]